news and insights
Explore our latest updates in terms of science, technology, people and our pipeline.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News categories
View all
People
Pipeline
Platform
Publications
Other
Kv1.3
October 18, 2024
By VRG Therapeutics
Press release
VRG Therapeutics Announces Monthly Dosing for Its Lead Program Targeting Kv1.3 for the Treatment of Atopic Dermatitis and Other Chronic Inflammatory Diseases
White arrow icon up and right direction redirecting to Partner with US page
People
January 2, 2024
By VRG Therapeutics
New member to the team: Mariann Kremlitzka, PhD
White arrow icon up and right direction redirecting to Partner with US page
People
January 2, 2024
By VRG Therapeutics
New member to the team: Ildikó Dósa
White arrow icon up and right direction redirecting to Partner with US page
Team
November 29, 2023
By VRG Therapeutics
CESAwards: We are regional finalists!
White arrow icon up and right direction redirecting to Partner with US page
Conference
People
November 27, 2023
By VRG Therapeutics
MBH Bank's Macronome Macroverse conference
White arrow icon up and right direction redirecting to Partner with US page
People
November 22, 2023
By VRG Therapeutics
Recognition of our student researcher
White arrow icon up and right direction redirecting to Partner with US page
CREATe-1
Kv1.3
November 6, 2023
By VRG Therapeutics
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023
White arrow icon up and right direction redirecting to Partner with US page
Press release
VRG Therapeutics is expanding into the Netherlands!
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
New VRG Tx patent application filed!
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!
Publication - Journal of Biological Chemistry
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study
BIO 2024 San Diego
First stage gating meeting of the year
New member to the team: Tamás Csikai
New member to the team: Gábor Oroszlán, PhD
New member to the team: Ambrus Gordos, PharmD
Meet in Italy for Life Sciences - Startup Breeding 2023
New member to the team: Lili Kovanecz-Jármi
New member to the team: Dr. Judit Matúz
International Biotech Days 2023
Bio Europe 2023 - Startup Spotlight
BIO-Europe 2023 Startup Spotlight
Meet in Italy for Life Sciences - Awards
Meet in Italy - Meet the startup: Vrg Therapeutics
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023
Recognition of our student researcher
MBH Bank's Macronome Macroverse conference
Milestone Alert: VRG Tx Launches Its In Vivo R&D Facility!
New member to the team: Ildikó Dósa
Publication - Journal of Biological Chemistry
VRG Therapeutics Advances VRG-145, a Synergistic Oral Combination for Migraine Prophylaxis, to Final Preclinical Stage
CESAwards: We are regional finalists!
New member to the team: Mariann Kremlitzka, PhD
New member to the team: Dr. Zoltán Urbányi
Press release: Experimental verification of our AI-powered drug discovery
Kv1.3
October 18, 2024
By VRG Therapeutics
Press release
White arrow icon up and right direction redirecting to Partner with US page
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
July 11, 2024
By VRG Therapeutics
New VRG Tx patent application filed!
White arrow icon up and right direction redirecting to Partner with US page
Team
June 11, 2024
By VRG Therapeutics
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!
White arrow icon up and right direction redirecting to Partner with US page
CREATe-1
May 24, 2024
By VRG Therapeutics
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study
White arrow icon up and right direction redirecting to Partner with US page
Previous
1
2
3
...
8
9
10
Next
Learn More
Million ways to improve life
Join our team
Partner With Us
Contact Us
Learn More
Million ways to improve life
Join our team
Partner With Us
Contact Us
Revolutionizing Biopharma Design through the power of the best science and technology platforms.
About
Our company
Our team
Contact us
Platform
Our Platform
CREATETM
Pipeline
Our pipeline
Careers
Careers
News
Latest news
Linkedin logo whiteWhite icon for redirect to contact page
Copyright© 2024 vrgtherapeutics.com
Privacy Policy
Cookies
Impressum
Revolutionizing Biopharma Design through the power of the best science and technology platforms.
About
Our company
Our team
Contact us
Platform
Our Platform
Pipeline
Our pipeline
Careers
Careers
News
Latest news
Linkedin logo whiteWhite icon for redirect to contact page
Copyright© 2024 vrgtherapeutics.com
Privacy Policy
Cookies
Impressum
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept